Behavior therapy attenuates clozapine-induced obsessions and compulsions
MacCabe, J.H.; Marks, I.M.; Murray, R.M.
Journal of Clinical Psychiatry 63(12): 1179-1180
2002
ISSN/ISBN: 0160-6689 PMID: 12530414 Document Number: 549268
Document emailed within 1 workday
Related Documents
Masellis, M.; Rector, N.A.; Richter, M.A. 2003: Quality of life in OCD: differential impact of obsessions, compulsions, and depression comorbidity Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 48(2): 72-77Herszkowicz, E. 1980: Behavior therapy of obsessions La Nouvelle Presse Medicale 9(33): 2300-2302
Nakamura, S.; Engel, J.; Goldstein, M. 1978: Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine Communications in Psychopharmacology 2(3): 185-190
Zalevskiĭ, G.V.; Rogovin, M.S. 1970: Fixed forms of behavior and their significance for neurological and psychiatric practice. (3. Compulsions--rituals--stereotypes) Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 70(11): 1725-1736
Ahsan, M.Iqbal.; Khan, R.Alam.; Masood, S.Mohammad.; Jaffery, A.; Jaffery, F.Ali. 2019: In vivo study to compare the effects of Choline with Fluoxetine and Clozapine for the modulation of cognitive behavior (Learning Memory and Exploratory Behavior) Pakistan Journal of Pharmaceutical Sciences 32(3 ): 1193-1199
Sandman, C.A.; Barron, J.L.; Colman, H. 1990: An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior American Journal of Mental Retardation: Ajmr 95(1): 93-102
Volpicelli, S.A.; Centorrino, F.; Puopolo, P.R.; Kando, J.; Frankenburg, F.R.; Baldessarini, R.J.; Flood, J.G. 1993: Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography Clinical Chemistry 39(8): 1656-1659
Soler Roibal, M.A.; Oca Bravo, L.; Montejo Iglesias, L.M. 1999: The clozapine-induced hypersalivation and its treatment Actas Espanolas de Psiquiatria 27(6): 408-411
Aggarwal, A.; Sharma, D.D. 2009: Amisulpride for clozapine induced sialorrhea Psychopharmacology Bulletin 42(4): 69-71
DasGupta, K.; Young, A. 1991: Clozapine-induced neuroleptic malignant syndrome Journal of Clinical Psychiatry 52(3): 105-107
Rolla, G.; Bucca, C.; Arossa, W.; Bugiani, M. 1987: Magnesium attenuates methacholine-induced bronchoconstriction in asthmatics Magnesium 6(4): 201-204
Silverstone, P.H. 1998: Prevention of clozapine-induced neutropenia by pretreatment with lithium Journal of Clinical Psychopharmacology 18(1): 86-88
Vasdev, S.; Mian, T.; Longerich, L.; Prabhakaran, V.; Parai, S. 1995: N-acetyl cysteine attenuates ethanol induced hypertension in rats Artery 21(6): 312-316
Belloni, F.L.; Hintze, T.H. 1991: Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilatation American Journal of Physiology 261(3 Pt 2): H720-H727
Hummer, M.; Kurz, M.; Barnas, C.; Saria, A.; Fleischhacker, W.W. 1994: Clozapine-induced transient white blood count disorders Journal of Clinical Psychiatry 55(10): 429-432
Praharaj, S.K.; Sarkhel, S.; Khanande, R.V.; Sinha, V.K. 2010: Complete resolution of clozapine-induced sialorrhea with low dose trihexyphenidyl Psychopharmacology Bulletin 43(4): 73-75
Greene, P.; Cote, L.; Fahn, S. 1993: Treatment of drug-induced psychosis in Parkinson's disease with clozapine Advances in Neurology 60: 703-706
Sánchez Bonome, L.; Barjau Romero, J.M.; Lara Muñoz, R.de.; Márquez Tejero, M.C. 2002: Clozapine-induced obsessive-compulsive disorder: a case report Actas Espanolas de Psiquiatria 30(5): 330-334
Lieberman, J.A.; Johns, C.A.; Kane, J.M.; Rai, K.; Pisciotta, A.V.; Saltz, B.L.; Howard, A. 1988: Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs Journal of Clinical Psychiatry 49(7): 271-277
Brown, T.E.; Wright, J.W.; Speth, R.C. 2003: Phospholipase C inhibitor U73122 attenuates the dipsogenic response induced by angiotensin Ii Proceedings of the Western Pharmacology Society 46: 61-63